标普和纳斯达克内在价值 联系我们

Blonder Tongue Laboratories, Inc. BDRL OTC

Other OTC • Technology • Communication Equipment • US • USD

SharesGrow Score
15/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Blonder Tongue Laboratories, Inc. (BDRL) .

本页证实的标准:

  • VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。

SharesGrow 综合评分: 15/100 其中 0/7 项标准通过。

SharesGrow 7-Criteria Score
15/100
SG Score
View full scorecard →
价值
N/A
No coverage
未來
N/A
No coverage
过去
25/100
→ Income
健康
0/100
Debt-to-Equity & liquidity
→ Health
护城河
27/100
→ Income
成长
15/100
→ Income
收入
10/100
→ Income

估值概览 — BDRL

估值倍数
P/E (TTM)0.0
前瞻 P/EN/A
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率0.01
EV/EBITDA0.0
每股数据
EPS (TTM)$-0.09
每股账面价值$0.00
每股营收$0.77
每股自由现金流$0.00
收益率与内在价值
盈利收益率N/A
股息收益率0.00%

EPS:实际 vs 预期

P/E Ratio & Earnings Yield

每股收益 (EPS) 历史

Year EPS(稀释) 营收 净利润 净利润率
2015 $-1.05 $20.94M $-6.77M -32.3%
2016 $-0.16 $22.51M $-1.2M -5.3%
2017 $-0.05 $23.28M $-384K -1.6%
2018 $-0.15 $21.71M $-1.34M -6.2%
2019 $-0.08 $19.84M $-742K -3.7%
2020 $0.30 $16.38M $3M 18.3%
2021 $0.01 $15.75M $84K 0.5%
2022 $-0.28 $18.12M $-3.71M -20.5%
2023 $-0.15 $13.21M $-2.12M -16%
2024 $-0.09 $11.17M $-1.25M -11.2%
联系我们
🎓
SharesGrow 学院
学习如何计算内在价值,发现被低估的股票。
每周在线课程
给我们留言